ARTICLE | Company News
Cleveland BioLabs deal
June 1, 2009 7:00 AM UTC
Cleveland BioLabs and Russian venture company Bioprocess Capital Ventures will form a JV to develop the biotech's portfolio of Curaxin compounds for cancer. Cleveland BioLabs will own 51% of the JV, a...